comparemela.com

Latest Breaking News On - Amneal pharmaceuticals company profile - Page 1 : comparemela.com

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $8.25 Consensus Target Price from Analysts

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average rating of “Buy” by the four ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on […]

Piper-sandler
News-ratings-for-amneal-pharmaceuticals-daily
Nasdaq
Amneal-pharmaceuticals-company-profile
Goldman-sachs-group
Amneal-pharmaceuticals
Amneal-pharmaceuticals-inc
Amneal-pharmaceuticals-stock-down
Sherbrooke-park-advisers
Atlanta-consulting-group-advisors
Hedge-funds-weigh-in-on-amneal-pharmaceuticals
Get-free-report

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 6.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s stock price shot up 6.4% on Tuesday . The company traded as high as $6.90 and last traded at $6.86. 685,390 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 1,502,379 shares. The stock had previously closed at $6.45. Analysts […]

Piper-sandler
Sherbrooke-park-advisers
Barclays
News-ratings-for-amneal-pharmaceuticals-daily
Amneal-pharmaceuticals
Atlanta-consulting-group-advisors
Nasdaq
Amneal-pharmaceuticals-company-profile
Amneal-pharmaceuticals-inc
Amneal-pharmaceuticals-stock-performance
Goldman-sachs-group
Institutional-investors-weigh-in-on-amneal-pharmaceuticals

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $7.31

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $7.31
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Amneal-pharmaceuticals
Nasdaq
Amneal-pharmaceuticals-stock-performance
News-ratings-for-amneal-pharmaceuticals-daily
Sherbrooke-park-advisers
Advisory-services
Goldman-sachs-group
Amneal-pharmaceuticals-inc
Barclays
Amneal-pharmaceuticals-company-profile
Institutional-trading-of-amneal-pharmaceuticals

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $5.86 and last traded at $5.84. 420,424 shares were traded during trading, a decline of 72% from the average session volume of 1,499,807 shares. The stock had previously closed at $5.73. Analyst Ratings Changes A […]

Piper-sandler
Barclays
Voloridge-investment-management
News-ratings-for-amneal-pharmaceuticals-daily
Barclays-plc
Group-plc
Institutional-investors-weigh-in-on-amneal-pharmaceuticals
Goldman-sachs-group
Amneal-pharmaceuticals
Amneal-pharmaceuticals-inc
Nasdaq
Amneal-pharmaceuticals-company-profile

Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volume

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 454,208 shares changed hands during mid-day trading, a decline of 69% from the previous session’s volume of 1,481,910 shares.The stock last traded at $5.96 and had previously closed at $5.81. Analysts Set New Price Targets Several research firms […]

Piper-sandler
Vanguard-group-inc
Blackrock-inc
Nasdaq
Millennium-management
Barclays
Amneal-pharmaceuticals-company-profile
News-ratings-for-amneal-pharmaceuticals-daily
Amneal-pharmaceuticals-stock
Amneal-pharmaceuticals-inc
Morgan-stanley
Goldman-sachs-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.